About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 238035, 12 pages
http://dx.doi.org/10.1155/2013/238035
Research Article

Combination with Methotrexate and Cyclophosphamide Attenuated Maturation of Dendritic Cells: Inducing Treg Skewing and Th17 Suppression In Vivo

Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wu Yi Road, Taiyuan 030001, China

Received 5 May 2013; Revised 1 August 2013; Accepted 15 August 2013

Academic Editor: Shigeo Koido

Copyright © 2013 Xiaoyang Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Lina, W. Conghua, L. Nan, and Z. Ping, “Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis,” Journal of Clinical Immunology, vol. 31, no. 4, pp. 596–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Lebre and P. P. Tak, “Dendritic cell subsets: their roles in rheumatoid arthritis,” Acta Reumatologica Portuguesa, vol. 33, no. 1, pp. 35–45, 2008. View at Scopus
  3. M.-C. Boissier, E. Assier, G. Falgarone, and N. Bessis, “Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm,” Joint Bone Spine, vol. 75, no. 4, pp. 373–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Banchereau and R. M. Steinman, “Dendritic cells and the control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Liu, G. D. Victora, T. A. Schwickert et al., “In vivo analysis of dendritic cell development and homeostasis,” Science, vol. 324, no. 5925, pp. 392–397, 2009. View at Scopus
  6. K. Liu and M. C. Nussenzweig, “Origin and development of dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 45–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. X. F. Li, L. Y. Zhang, H. Q. Niu, et al., “The short-term efficacy and safety of methotrexate and cyclophosphamide treatment of rheumatoidarthritis: a randomized, single-blinded and controlled study,” Chinese Journal of Rheumatology, vol. 14, no. 2, pp. 110–114, 2010.
  8. C. Lina, W. Conghua, L. Nan, and Z. Ping, “Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis,” Journal of Clinical Immunology, vol. 31, no. 4, pp. 596–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. H. Wang, X. F. Li, F. C. Zhang, et al., “Effect of combined methotrexate and cyclophosphamide therapy on the cyclin D1 expression in the synovium of rats with collagen induced arthritis,” Chinese Journal of Rheumatology, vol. 12, no. 12, pp. 812–815, 2008.
  10. Z. Zhou, L. Jinpiao, H. Rongfen, et al., “Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4/5 signaling in vivo,” International Immunopharmacology, vol. 14, no. 3, pp. 275–282, 2012. View at Publisher · View at Google Scholar
  11. J. Chen, J. Li, H. Gao, et al., “Comprehensive evaluation of different T-helper cell subsets differentiation and function in rheumatoid arthritis,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 535361, 6 pages, 2012. View at Publisher · View at Google Scholar
  12. S. Raychaudhuri, E. F. Remmers, A. T. Lee et al., “Common variants at CD40 and other loci confer risk of rheumatoid arthritis,” Nature Genetics, vol. 40, no. 10, pp. 1216–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. B. Klarenbeek, M. Güler-Yüksel, S. M. Van Der Kooij et al., “The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the best study,” Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 1039–1046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Tanaka, T. Takeuchi, T. Mimori et al., “Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by remicade in RA) study,” Annals of the Rheumatic Diseases, vol. 69, no. 7, pp. 1286–1291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Conigliaro, R. A. Benson, A. Patakas et al., “Characterization of the anticollagen antibody response in a new model of chronic polyarthritis,” Arthritis and Rheumatism, vol. 63, no. 8, pp. 2299–2308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. B. Nickdel, P. Conigliaro, G. Valesini et al., “Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 1059–1066, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Schwartz, “T cell anergy,” Annual Review of Immunology, vol. 21, pp. 305–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. B. Lutz and G. Schuler, “Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?” Trends in Immunology, vol. 23, no. 9, pp. 445–449, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. W.-P. Min, D. Zhou, T. E. Ichim et al., “Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance,” Journal of Immunology, vol. 170, no. 3, pp. 1304–1312, 2003. View at Scopus
  20. K. Schäkel, “Dendritic cells—why can they help and hurt us,” Experimental Dermatology, vol. 18, no. 3, pp. 264–273, 2009. View at Publisher · View at Google Scholar
  21. X. Zhang, “Dendritic cells and immunologic reconstruction in experimental systemic lupus erythematosus,” Chinese Journal of Rheumatology, vol. 7, pp. 521–522, 2003.
  22. C. Dong, “TH17 cells in development: an updated view of their molecular identity and genetic programming,” Nature Reviews Immunology, vol. 8, no. 5, pp. 337–348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Xiao, B. Zhu, H. Jin et al., “Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells,” European Journal of Immunology, vol. 41, no. 6, pp. 1539–1549, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Cannon, H. Goyne, P. J. B. Stone, and M. Chiriva-Internati, “Dendritic cell vaccination against ovarian cancer-tipping the Treg/TH17 balance to therapeutic advantage?” Expert Opinion on Biological Therapy, vol. 11, no. 4, pp. 441–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Y. Kao, M. Zhang, M. J. Miller et al., “Helicobacter pylori immune escape is mediated by dendritic cell-induced treg skewing and Th17 suppression in mice,” Gastroenterology, vol. 138, no. 3, pp. 1046–1054, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Zhou, J. E. Lopes, M. M. W. Chong et al., “TGF-Β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function,” Nature, vol. 453, no. 7192, pp. 236–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Lochner, L. Peduto, M. Cherrier et al., “In vivo equilibrium of proinflammatory IL-17+and regulatory IL-10+Foxp3+ ROR-gamma t+ T cells,” Journal of Experimental Medicine, vol. 205, no. 6, pp. 1381–1393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. X. O. Yang, R. Nurieva, G. J. Martinez et al., “Molecular antagonism and plasticity of regulatory and inflammatory T cell programs,” Immunity, vol. 29, no. 1, pp. 44–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Zanoni and F. Granucci, “Regulation of antigen uptake, migration, and lifespan of dendritic cell by toll-like receptors,” Journal of Molecular Medicine, vol. 88, no. 9, pp. 873–880, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Watts, M. A. West, and R. Zaru, “TLR signalling regulated antigen presentation in dendritic cells,” Current Opinion in Immunology, vol. 22, no. 1, pp. 124–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Jin, L. Zhang, J. Zheng, and Y. Zhao, “The inflammatory Th 17 subset in immunity against self and non-self antigens,” Autoimmunity, vol. 41, no. 2, pp. 154–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Pasare and R. Medzhitov, “Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells,” Science, vol. 299, no. 5609, pp. 1033–1036, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Jin, L. Zhang, J. Zheng, and Y. Zhao, “The inflammatory Th 17 subset in immunity against self and non-self antigens,” Autoimmunity, vol. 41, no. 2, pp. 154–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Iwanami, I. Matsumoto, Y. Tanaka-Watanabe et al., “Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase,” Arthritis and Rheumatism, vol. 58, no. 3, pp. 754–763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Afzali, G. Lombardi, R. I. Lechler, and G. M. Lord, “The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease,” Clinical and Experimental Immunology, vol. 148, no. 1, pp. 32–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. X. L. Li, Y. Liu, L. L. Cao, et al., “Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines,” Molecular and Cellular Neurosciences, vol. 56, pp. 85–95, 2013. View at Publisher · View at Google Scholar
  38. J. Dokić, S. Tomić, M. Marković, P. Milosavljević, and M. Colić, “Mesenchymal stem cells from periapical lesions modulate differentiation and functional properties of monocyte-derived dendritic cells,” European Journal of Immunology, vol. 43, no. 7, pp. 1862–1872, 2012. View at Publisher · View at Google Scholar
  39. S. Z. Y. Lo, J. H. Steer, and D. A. Joyce, “Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway,” Arthritis Research and Therapy, vol. 13, no. 1, article R24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. C. DeOliveira, S. C. Acedo, É. M. Ferreira Gotardo et al., “Effects of methotrexate on inflammatory alterations induced by obesity: an in vivo and in vitro study,” Molecular and Cellular Endocrinology, vol. 361, no. 1-2, pp. 92–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Bulgarelli, A. A. Martins Dias, B. Caramelli, and R. C. Maranhão, “Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits,” Journal of Cardiovascular Pharmacology, vol. 59, no. 4, pp. 308–314, 2012. View at Publisher · View at Google Scholar · View at Scopus